Thomson Medical Group Ltd. · SGX:A50
Thomson Medical — Shareholder Meeting (October 2021)
14 slides from Thomson Medical's shareholder meeting presentation, Oct 22, 2021
Slide 1: Staying resilient and forging ahead
THOMSON MEDICAL GROUP LIMITED Staying resilient and forging ahead 21st Annual General Meeting | Oct 22, 2021 | Singapore Thursday, 25 April 2019
Slide 2: Disclaimer
Disclaimer NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION. THIS ANNOUNCEMENT SHALL NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITI
Slide 3: Agenda
Agenda • Business Overview • Financial Review • Growth Plans
Slide 4: Business Overview
THOMSON MEDICAL GROUP Business Overview
Slide 5: Key Corporate Milestones
Key Corporate Milestones Officially opened a dedicated Commenced operations at Thomson learning centre for children with Wellth@Paragon, an integrated facility houses Debut Bond Offering, learning needs services for fertility, TCM, sports medicine, the Group’s first step into preventive medicine and
Slide 6: Singapore Healthcare Assets
Singapore Healthcare Assets Thomson Medical Centre • Flagship Thomson Medical Centre Sembawang • 39 clinics and centres islandwide Choa Chu Kang Sengkang/Punggol Novena Medical Centre Bukit Batok/ Tampines Toa Payoh Bukit Panjang Serangoon Jurong East Thomson Novena Orchard Novena Specialist Centre
Slide 7: Malaysia Healthcare Assets
Malaysia Healthcare Assets Located next to Kota Damansara Mass Rapid Transit station and 3km away from the North Klang Valley Expressway Thomson Hospital Kota Damansara • Flagship Thomson Hospital Kota Current Expansion plan Operational by end 2021 Damansara Penang • 8 fertility clinics and other ce
Slide 8: Financial review
THOMSON MEDICAL GROUP
Slide 9: Group Financial Highlights – FY2021
Group Financial Highlights – FY2021 Strong results amid Healthy balance sheet Final Dividend COVID challenges 11.2% growth in Revenue in Strong cash position of Board of Directors FY2021 to $240.4m $122.7m as at 30 June 2021 recommend final dividend of 0.015 cents per share 40.6% growth in EBITDA in
Slide 10: Business Segments
Business Segments REVENUE EBITDA1 $97.7m $78.8m $19.2m $7.9m 40.7% 36.5% 28.3% 16.2% FY2021 FY2020(2) FY2021 FY2020(2) $142.4m $137.0m $48.6m $40.9m 59.3% 63.5% 71.7% 83.8% • Continued revenue and EBITDA growth across both business segments • Stronger growth in the specialised services due to higher
Slide 11: Geographical Segments
Geographical Segments REVENUE EBITDA1 $66.0m $63.0m $12.4m $10.8m 27.5% 29.2% 18.6% 22.7% FY2021 FY2020(2) FY2021 FY2020(2) $174.4m $153.1m $54.4m $36.7m 72.5% 70.8% 81.4% 77.3% • Continued revenue and EBITDA growth across in Singapore and Malaysia • Stronger growth in Singapore driven by higher pro
Slide 12: Growth Plans
THOMSON MEDICAL GROUP Growth Plans
Slide 13: Growth Plans
Growth Plans Thomson Hospital Kota Damansara (THKD) • Newly completed expansion wing received the Certificate of Completion and Compliance (CCC) on 5 May 2021 and expected to be operational around end 2021 • New building will house a brand new Cancer & Theranostics Centre, Nuclear Medicine Centre, E
Slide 14: TMG 21st Annual General Meeting Presentation
TMG 21st Annual General Meeting Presentation ir@thomsonmedical.com
Thomson Medical Group — Shareholder Meeting (October 2021) on 6ix